• SENSEX 77,414.92
    -191.51 (--0.25%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Hind.Aeronautics
    4,294.00 5,675.00(%)
  • Zomato Ltd
    200.50 146.85(%)
  • Aster DM Health.
    504.00 558.30(%)
  • Reliance Industr
    1,269.05 1,156.00(%)
  • Tata Motors
    684.90 1,179.05(%)
  • Jio Financial
    232.25 394.70(%)
  • Mazagon Dock
    2,635.55 920.48(%)
  • Vodafone Idea
    6.77 6.60(%)
  • HDFC Bank
    1,836.40 1,880.00(%)
  • Suzlon Energy
    56.40 37.95(%)
  • M & M
    2,635.10 1,872.45(%)
  • IDFC First Bank
    54.63 52.60(%)
  • Dixon Technolog.
    13,019.00 7,100.05(%)
  • I R F C
    123.65 108.05(%)
  • Bharat Electron
    306.50 340.35(%)
  • Adani Energy Sol
    863.60 588.25(%)
  • Asian Paints
    2,322.35 2,125.00(%)
  • Reliance Power
    44.75 54.25(%)
  • Hindustan Copper
    218.75 195.35(%)
  • IndusInd Bank
    643.70 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Par Drugs & Chemicals Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 66408.0
  • ISIN : INE04LG01015
84.93 -4 (-5.00%)
  • As on 31 Mar 2025 (EOD)

  • Today’s Low

    84.93

  • Today’s High

    91.90

  • Open

    89.00

  • Perv Close

    89.40

  • 52W Low

    84.93

  • 52W High

    348.45

Key Indicators

  • P/E(TTM)

    6.77

  • Mar.Cap (₹Cr.)

    104.50

  • Div & Yield %

    0.00

  • Book Value(₹)

    78.64

  • Debt-Equity Ratio

    -5.00

  • AGM Date

    28-Mar-2025

  • EPS

    12.54

  • P/E Ratio

    6.77

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    104.50

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    12.30

  • BV (₹)

    78.60

  • Sales( ₹ in Cr.)

    95.64

  • NP (in Cr.)

    14.49

  • NP Var(%)

    29.0

  • Div%

    0.0

  • CPS (₹)

    14.60

  • EPS (₹)

    11.80

  • Traded Value (₹ in Lakhs)

    104.50

  • 52 Week High

    348.45

  • 52 Week Low

    84.93

  • Price BSE

    0.0

  • Price NSE

    85.00

  • Market Capital( in Cr.)

    104.50

  • P/C Ratio

    5.80

  • P/E Ratio

    7.20

  • Price Vs.BV

    11.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 95.64 95.75 84.85 69.07 55.85 46.32
Excise Duty 95.11 95.10 83.98 68.19 55.10 45.58
Net Sales 95.64 95.75 84.85 69.07 55.85 46.32
Other Income 0.24 0.24 0.18 0.19 0.10 0.09
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 95.88 95.99 75.26 60.94 55.95 46.41
EXPENDITURE :
Raw Materials 95.11 95.10 83.98 68.19 55.10 45.58
Power & Fuel Cost 95.11 95.10 83.98 68.19 55.10 45.58
Employee Cost 5.50 4.89 4.10 3.98 4.11 3.64
Other Manufacturing Expenses 1.40 0.22 0.16 0.01 0.18 0.02
Selling & Administrative Expenses 10.16 9.60 8.22 5.62 4.59 3.84
Miscellaneous Expenses 1.40 0.22 0.16 0.01 0.18 0.02
Less : Pre-operative Expenses Capitalised :
Total Expenditure 76.37 80.91 62.56 48.20 49.96 43.12
Operating Profit 21.97 22.51 17.51 13.25 13.86 11.40
Interest 0.11 0.13 0.45 0.64 0.79 1.96
Gross Profit 19.52 15.08 12.70 14.73 5.99 3.29
Depreciation 3.44 3.23 3.28 2.82 2.76 3.04
Profit Before Tax 19.52 15.08 12.70 14.73 5.99 3.29
Tax 4.98 3.80 3.35 3.36 1.00 0.68
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.04 -0.05 0.14 -0.25 0.23 0.10
Reported Net Profit 14.50 11.33 9.21 11.61 4.76 2.51
Extraordinary Items 19.52 15.08 12.70 14.73 5.99 3.29
Adjusted Net Profit 14.50 11.33 9.21 11.61 4.76 2.51
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 1.54 0.00
P & L Balance carried down 14.50 11.33 9.21 11.61 4.76 2.51
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 25.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 2.50 0.00
Earnings Per Share-Unit Curr 11.78 9.21 7.49 18.87 7.75 5.60
Book Value 0.00 0.00 0.00 0.00 1.54 0.00
Book Value(Adj)-Unit Curr 0.00 0.00 0.00 0.00 1.54 0.00

Shareholding Pattern

  • Promoter Group

    73.37%

  • Public Share Holding

    26.63%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 9,027,750 73.37 9,027,750 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 9,027,750 73.37 9,027,750 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 171,397 1.39 171,397 48
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 146,515 1.19 146,515 161
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 133,641 1.09 133,641 239
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 235,312 1.91 235,312 7
Individuals holding nominal share capital up to Rs. 1 lakh 2,577,430 20.95 2,577,430 16,729
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,276,886 26.63 3,276,886 17,193
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 12,304,636 100.00 12,304,636 17,199

Company Background

Par Drugs & Chemicals LtdPharmaceuticals - Indian - Bulk Drugs

  • Par Drugs & Chemicals Ltd
  • BSE Code : 66408.0
  • ISIN : INE04LG01015

  • Incorporation Year

    1999

  • Registered Office

    805 Dwarkesh Complex
    RC Dutt Road Alkapuri, Vadodara,
    Gujarat-390007

  • Telephone

    91-265-2332018

  • FAX

  • Chairman

    FALGUN VALLABHBHAI SAVANI

  • Managing Director

  • Company Secretary

  • Auditor

    Sarupria Somani & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Link Intime India Pvt Ltd
    5th Floor 506 to 508,
    ABC-I Off C G Road ,Navrangpura
    Mumbai - Ahmedabad-380009

Par Drugs & Chemicals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Par Drugs & Che. 84.93 95.88 95.64 6.77 25.01
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92